Skullcapflavone II induces G2/M phase arrest in hepatic stellate cells and suppresses hepatic fibrosis
The abovementioned mechanisms of action of Skullcapflavone II substantiate its prospective clinical application against HF.
Authors
- Guoyi Rong
- Wenfu Cao (ORCID: https://orcid.org/0000-0001-7539-4866)
- Shang Wang (ORCID: https://orcid.org/0000-0001-7477-2861)
- Jun Liu (ORCID: https://orcid.org/0000-0001-7161-0533)
- Yi Yang (ORCID: https://orcid.org/0000-0001-6525-3920)
Institutions
- Army Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- European Journal of Pharmacology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1016/j.ejphar.2025.177522
- Citations
- 2
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- National Natural Science Foundation of China